Prevention of the expression of inducible nitric oxide synthase by aminoguanidine or aminoethyl-isothiourea in macrophages and in the rat

被引:74
作者
Ruetten, H [1 ]
Thiemermann, C [1 ]
机构
[1] ST BARTHOLOMEWS HOSP,COLL MED,WILLIAM HARVEY RES INST,LONDON EC1M 6BQ,ENGLAND
关键词
D O I
10.1006/bbrc.1996.1206
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An enhanced formation of nitric oxide (NO) following the induction of the inducible isoform of NOS (iNOS) has been implicated in the pathogenesis of circulatory shock and inflammation. This study elucidates the effects of the NOS inhibitors aminoethyl-isothiourea (AE-ITU), aminoguanidine (AG), N-G-methyl-L-arginine (L-NMMA) or N-omega-Nitro-L-arginine methyl ester (L-NAME) on the expression of iNOS protein lipopolysaccharide (LPS) in macrophages and the rat (lung homogenates). The expression of iNOS protein was detected by Western blot analysis using a specific iNOS antibody. In the absence of LPS, the iNOS protein was expressed neither in macrophages nor in the lung. LPS (1 mu g . ml(-1)) resulted in the expression of iNOS protein in macrophages, which was significantly inhibited by pretreatment of cells with AE-ITU or AG, but not by L-NMMA or L-NAME. In addition, LPS (10 mg . kg(-1), i.v.) also caused an increase in the expression of iNOS protein in lungs obtained from rats at 6 h after LPS, which was significantly reduced by treatment of LPS-rats with AE-ITU or AG, but not with L-NMMA or L-NAME. Thus, AE-ITU or AG inhibit not only iNOS activity, but also the induction of iNOS protein in vitro and in vivo caused by endotoxin. (C) 1996 Academic Press, Inc.
引用
收藏
页码:525 / 530
页数:6
相关论文
共 24 条
[1]   INVOLVEMENT OF TYROSINE KINASE IN THE INDUCTION OF CYCLOOXYGENASE AND NITRIC-OXIDE SYNTHASE BY ENDOTOXIN IN CULTURED-CELLS [J].
AKARASEREENONT, P ;
MITCHELL, JA ;
APPLETON, I ;
THIEMERMANN, C ;
VANE, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1522-1528
[2]  
[Anonymous], 1983, J IMMUNOL METH
[3]   CALMODULIN IS A SUBUNIT OF NITRIC-OXIDE SYNTHASE FROM MACROPHAGES [J].
CHO, HJ ;
XIE, QW ;
CALAYCAY, J ;
MUMFORD, RA ;
SWIDEREK, KM ;
LEE, TD ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (02) :599-604
[4]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556
[5]  
DEKIMPE SJ, 1995, BRIT J PHARMACOL, V114, P1317
[6]  
DIENERMAN JL, 1993, CIRC RES, V73, P217
[7]  
GREEN LC, 1981, P NATL ACAD SCI USA, V78, P7734
[8]   MACROPHAGE AND ENDOTHELIAL-CELL NITRIC-OXIDE SYNTHESIS - CELL-TYPE SELECTIVE-INHIBITION BY NG-AMINOARGININE, NG-NITROARGININE AND NG-METHYLARGININE [J].
GROSS, SS ;
STUEHR, DJ ;
AISAKA, K ;
JAFFE, EA ;
LEVI, R ;
GRIFFITH, OW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (01) :96-103
[9]   NITRIC-OXIDE SYNTHESIS IN THE CNS, ENDOTHELIUM AND MACROPHAGES DIFFERS IN ITS SENSITIVITY TO INHIBITION BY ARGININE ANALOGS [J].
LAMBERT, LE ;
WHITTEN, JP ;
BARON, BM ;
CHENG, HC ;
DOHERTY, NS ;
MCDONALD, IA .
LIFE SCIENCES, 1991, 48 (01) :69-75
[10]   NITRIC-OXIDE - A NEW ENDOGENOUS IMMUNOMODULATOR [J].
LANGREHR, JM ;
HOFFMAN, RA ;
LANCASTER, JR ;
SIMMONS, RL .
TRANSPLANTATION, 1993, 55 (06) :1205-1212